To determine if we could recapitulate this dynamic regulation of EZH2 in response to PI3K inactivation in AML cell lines, we treated NOMO1 and MOLM14 cells with copanlisib over the course of two days. The gene discussed is EZH2; the disease is acute myeloid leukemia.